This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Apple seeks summary judgment against AliveCor's US Sherman Act and California UCL claims

( July 27, 2023, 00:46 GMT | Official Statement) -- MLex Summary: Apple asked a US judge to grant its summary judgment motion that it didn't violate Section 2 of the Sherman Act, nor California's Unfair Competition Law, saying AliveCor can't establish that Apple’s conduct was unlawful or unfair in violation of the UCL. In introducing its new Heart Rate Neural Network algorithm in 2018, Apple said it was able to identify "more accurate heartrate values in almost all circumstances — including during exercise, Workout Mode’s intended purpose — and thereby delivered better heartrate readings to millions of consumers and thousands of developers. Apple’s conduct was, in short, the very kind of 'technological innovation' that antitrust laws try to foster."See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections